๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Jinan
Clinical trial register · China

Clinical Trials in Jinan, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Qilu Hospital of Shandong University114 Qianfoshan Hospital32 Shandong Cancer Hospital and Institute31 AstraZeneca26 Shandong University26
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Jinan

785 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Combination of CT and Ultrasound Radiomics Combined With Liquid Biopsy to Predict Neoadjuvant Chemotherapy Response in Patients With Locally Advanced Gastric Cancer
NCT07697079Gastric Cancer
Liu Yang
Observational
300
Jinan
2027-02-01
Not yet open
A Single-center, Randomized, Open-label, Parallel-design Clinical Study to Evaluate the Pharmacokinetic Effects of Itraconazole, Fluconazole or Efavirenz on a Single Dose of Clifutinib in Healthy Participants
NCT07341672Healthy Adult Subject
Sunshine Lake Pharma Co., Ltd.
Phase 1
80
Jinan
2026-12-31
Not yet open
ZR001 Chemogenetics Gene Therapy Study in Patients With Parkinson's Disease
NCT07718659Parkinson's Disease (PD), Parkinsonian Disorders
Qianfoshan Hospital
Phase 1
8
Jinan
2026-12-01
Not yet open
A Study of Orforglipron (LY3502970) in Chinese Participants With Obesity or Overweight and Weight-Related Health Problems
NCT07790861Obesity, Overweight
Eli Lilly and Company
Phase 3
192
Chengdu, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Luoyang Shi, Nanchang
2026-12
Not yet open
Real-World Effectiveness of Depemokimab in Allergic Bronchopulmonary Aspergillosis With Severe Eosinophilic Asthma
NCT07828327Allergic Bronchopulmonary Aspergillosis, ABPA, Severe Eosinophilic Asthma
Qianfoshan Hospital
Not applicable
10
Jinan
2026-11-01
Not yet open
FH-006 Versus Investigator's Choice of Chemotherapy in Patients With Locally Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma Who Have Failed Prior PD-1/PD-L1 Inhibitor Combined With Platinum-Based Chemotherapy.
NCT07790380Locally Advanced, Recurrent or Metastatic ESCC Patients Who Have Failed Prior PD-1/PD-L1 Inhibitors Combined With Platinum-based Chemotherapy
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
480
Jinan
2026-10-10
Not yet open
EECP for Erectile Dysfunction in Elderly Hypertensive Patients
NCT07831551Hypertension, Erectile Dysfunction
Qilu Hospital of Shandong University
Not applicable
106
Shenzhen, Jinan
2026-10-01
Not yet open
Early Lumbar Drainage for Intraventricular Hemorrhage
NCT07625449Intraventricular Hemorrhage, Cerebral Hemorrhage
Second Affiliated Hospital of Nanchang University
Not applicable
392
Fuzhou, Jinan, Taizhou, Changde, Dezhou, Ganzhou, Guiyang, Hangzhou
2026-10
Not yet open
Safety and Efficacy Evaluation of Single-Port Versus Multi-Port Robotic-Assisted Radical Distal Gastrectomy for Gastric Cancer
NCT07828899STOMACH NEOPLASM, Robotic Surgical Procedures
First Affiliated Hospital of Wenzhou Medical University
Not applicable
212
Shijiazhuang, Jinan, Wenzhou, Beijing, Chongqing
2026-10
Not yet open
A Extension Study to Evaluate the Safety and Efficacy of HRS-7249 in Patients With Hypertriglyceridemia
NCT07799688Hyperlipidemia
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 2
400
Jinan, Shanghai
2026-09-30
Recruiting
A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum
NCT07811193Colorectal Adenocarcinoma
Vividion Therapeutics, Inc.
Phase 2
140
Bengbu, Beijing, Fuzhou, Guangzhou, Harbin, Wuhan, Jinan, Shanghai
2026-09-11
Not yet open
Comparison of the Efficacy of Saccharomyces Boulardii and Rifaximin in the Treatment of Small Intestinal Bacterial Overgrowth
NCT07815548Small Intestinal Bacterial Overgrowth Syndrome (SIBO)
Shandong University
Phase 4
222
Jinan
2026-09-10
Not yet open
A Clinical Trial of LBL-024 Combination Drug in Patients With Metastatic Colorectal Carcinoma
NCT07791758Metastatic Colorectal Carcinoma
Nanjing Leads Biolabs Co.,Ltd
Phase 1/2
369
Guangzhou, Guilin, Nanning, Luoyang, Nanchang, Jinan, Shanghai, Chengdu
2026-09-04
Not yet open
Study of SG301 for Renal AMR After Transplantation
NCT07764627Antibody Mediated Rejection
Hangzhou Sumgen Biotech Co., Ltd.
Phase 2
10
Guangzhou, Nanning, Zhengzhou, Changsha, Jinan, Chengdu, Hangzhou
2026-09-01
Not yet open
SKB264 Plus KL-A167 in MSI-H/dMMR Advanced Gynecological Malignancies
NCT07738757Recurrent or Metastatic MSI-H/dMMR Gynecological Malignancies
Peking Union Medical College Hospital
Phase 2
80
Jinan, Beijing
2026-09-01
Not yet open
Real-World Effectiveness of Tezepelumab in Allergic Bronchopulmonary Aspergillosis
NCT07757841Allergic Bronchopulmonary Aspergillosis, Severe Asthma, ABPA
Qianfoshan Hospital
Not applicable
10
Jinan
2026-09-01
Not yet open
A Study of Mezagitamab in Adults With Late Antibody-Mediated Rejection (AMR) After a Kidney Transplant
NCT07613359Antibody-Mediated Rejection (AMR)
Takeda
Phase 2
36
Beijing, Guangdong, Nanning, Wuhan, Xi'an, Jinan, Chengdu, Hangzhou
2026-09-01
Not yet open
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
NCT07794579Overweight, Prediabetic State, Prehypertension, Obesity, Abdominal
Eli Lilly and Company
Phase 3
2,001
Chengdu, Hefei, Jinan, Luoyang Shi, Nanjing, Ningbo, Qinhuangdao Shi, Tianjin
2026-09
Not yet open
A Clinical Trial of TQF3250 Capsules in Overweight/Obese Trial Participants With Poor Weight Control Through Simple Lifestyle Intervention
NCT07798284Overweight/Obesity
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1
80
Beijing, Guangzhou, Zhengzhou, Wuhan, Xianning, Jinan, Shanghai, Luzhou
2026-09
Not yet open
A Study of GFH276 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors and Pancreatic Ductal Adenocarcinoma (PDAC) Harboring RAS Mutation
NCT07678593Advanced Solid Tumors Cancer, Pancreatic Ductal Adenocarcinoma, RAS Mutation
Genfleet Therapeutics (Shanghai) Inc.
Phase 1/2
222
Beijing, Guangzhou, Harbin, Zhengzhou, Wuhan, Shenyang, Xi'an, Jinan
2026-09
Not yet open
Yiqi Fumai Lyophilized Injection for Chronic Heart Failure Caused by Coronary Heart Disease
NCT07803471Chronic Heart Failure, Heart Failure With Reduced Ejection Fraction (HFrEF), Coronary Heart Disease (CHD)
China Academy of Chinese Medical Sciences
Not applicable
100
Guangzhou, Zhengzhou, Jinan, Tianjin
2026-09
Not yet open
Birelentinib Plus R-CHOP in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (TAI-SHAN19)
NCT07712588Diffuse Large B-Cell Lymphoma (DLBCL)
Dizal Pharmaceuticals
Phase 2/3
880
Chongqing, Harbin, Changsha, Jinan, Shanghai
2026-09
Not yet open
Guided Laminectomy With Augmented Duroplasty for Acute Traumatic Spinal Cord Injury
NCT07733401Spinal Cord Injury, Acute Spinal Cord Injury (SCI)
Xuanwu Hospital, Beijing
Not applicable
80
Beijing, Guangzhou, Maoming, Cangzhou, Shijiazhuang, Chifeng, Dezhou, Jinan
2026-09
Not yet open
Sequential PD-1 Antibody and Pegylated Interferon Therapy for Nucleos(t)Ide Analogue-suppressed Chronic Hepatitis B
NCT07809165Chronic Hepatitis B
Beijing 302 Hospital
Not applicable
60
Jinan, Taiyuan, Xi'an
2026-09
Not yet open
A Phase II Clinical Study of SHR-7787 Injection Combined With SHR-1316 Injection in Patients With LS-SCLC
NCT07798947Limited-stage Small-cell Lung Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 2
120
Jinan
2026-09
Recruiting
A Study Comparing BL-B01D1 in Combination With Osimertinib Versus Osimertinib Alone in Patients With Locally Advanced, Unresectable EGFR-mutated Non-small Cell Lung Cancer(Stage III) Whose Disease Has Not Progressed Following Definitive Platinum-based Chemoradiation Therapy(PANKU-Lung08)
NCT07640789Non-small Cell Lung Cancer Stage III
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
418
Jinan
2026-08-28
Recruiting
Rupatifen Fumarate Capsules in Patients With Seasonal Allergic Rhinitis
NCT07711262Seasonal Allergic Rhinitis
Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd.
Phase 3
550
Baoding, Cangzhou, Shijiazhuang, Zhangjiakou, Baotou, Chifeng, Yinchuan, Jinan
2026-08-18
Recruiting
Short-Course Radiotherapy Followed by CAPOX With or Without Iparomlimab and Tuvonralimab in pMMR/MSS Locally Advanced Rectal Cancer
NCT07686640Local Advanced Rectal Cancer, Radiotherapy, Immunotherapy
Shandong Cancer Hospital and Institute
Phase 3
180
Jinan
2026-08-15
Not yet open
HMPL-A830 in Solid Tumors
NCT07718581Solid Tumor, Adult
Hutchmed
Phase 1/2
147
Beijing, Changsha, Chengdu, Guangzhou, Jinan, Nanjing, Taiyuan
2026-08-15
Recruiting
SKB500 Combinations in Patients With Esophageal Squamous Cell Carcinoma
NCT07700667Esophageal Squamous Cell Carcinoma
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 2
120
Changchun, Chengdu, Chongqing, Fuzhou, Haโ€™erbin, Jinan, Kunming, Luoyang
2026-08-13
Recruiting
Evaluation of Fecal Multi-target Biomarkers in the Screening of Digestive Tract Cancers
NCT07600125Gastric Cancer, Colorectal Cancer
Xijing Hospital
Observational
5,000
Xi'an, Dalian, Hami, Heze, Jinan, Langfang, Liuโ€˜an, Qingdao
2026-08-10
Recruiting
A Multicenter Prospective Observational Cohort Study for Digestive Tract Tumor Screening Using Multi-Target Blood and Fecal Biomarkers
NCT07769892Gastrointestinal Cancers
Xijing Hospital
Observational
5,000
Zhaoqing, Xi'an, Jinan, Mianyang, Wuwei, Wuxi
2026-08-10
Not yet open
Evaluation of NWRD09 for HPV-16 Related Cervical HSIL
NCT07712692High-grade Squamous Intraepithelial Lesion (HSIL)
Newish Biotech (Wuxi) Co., Ltd.
Phase 2
156
Beijing, Chongqing, Lanzhou, Baoding, Zhengzhou, Nanjing, Changchun, Jinan
2026-08-01
Not yet open
Yanlishuang Buccal Dropping Pills for Acute Pharyngitis
NCT07761013Acute Pharyngitis
Beijing University of Chinese Medicine
Not applicable
400
Guangzhou, Guiyang, Harbin, Nanjing, Nanchang, Jinan, Shanghai, Chengdu
2026-08-01
Not yet open
Prophylactic IABP in Delayed-Presentation Anterior STEMI
NCT07761455Acute Anterior ST-Segment Elevation Myocardial Infarction
Qilu Hospital of Shandong University
Not applicable
504
Jinan, Jining, Qingdao, Beijing
2026-08-01
Not yet open
A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Primary AL Amyloidosis
NCT07765524Primary Light Chain (AL) Amyloidosis
Shenzhen Fosun Kairos Biotechnology Co., Ltd.
Phase 1/2
32
Guangzhou, Nanning, Zhengzhou, Wuhan, Nanjing, Jinan, Shanghai, Chengdu
2026-08
Not yet open
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
NCT07759245Pulmonary Disease, Chronic Obstructive
Eli Lilly and Company
Phase 2
606
Baotou, Beijing, Chengdu, Guangzhou, Jiangyin, Jinan, Pingxiang, Shanghai
2026-08
Not yet open
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
NCT07775300Depressive Disorder, Major
Eli Lilly and Company
Phase 3
1,000
Beijing, Chaohu, Jinan, Linfen, Shanghai, Suzhou, Tianjin, Wenzhou
2026-08
Not yet open
Clinical Study of Spectral CT Verida
NCT07759011Volunteers
Philips Clinical & Medical Affairs Global
Not applicable
80
Jinan
2026-07-30
Active, closed
Clinical Application of an AI-based Dissection Trajectory Prediction System (ADTPS) in Endoscopic Submucosal Dissection
NCT07757906Esophageal Squamous Cell Carcinoma (ESCC), High-Grade Intraepithelial Neoplasia, AI-Based Dissection Trajectory Prediction System
Qilu Hospital of Shandong University
Not applicable
160
Jinan
2026-07-29
Recruiting
A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLC
NCT07586202Carcinoma, Non-Small-Cell Lung
Janssen Research & Development, LLC
Phase 2
68
Cheng Du Shi, Chengdu, Guangzhou, Jinan, Tianjin
2026-07-28
Recruiting
Efficacy and Safety of Ravulizumab in Chinese Adults Participants With Generalized Myasthenia Gravis (gMG)
NCT07596784Generalized Myasthenia Gravis, gMG
Alexion Pharmaceuticals, Inc.
Phase 3
20
Beijing, Changchun, Fuzhou, Jinan, Shanghai, Shijiazhuang, Taiyuan, Tianjin
2026-07-20
Recruiting
Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity Study of Ravulizumab in Chinese Adults With Neuromyelitis Optica Spectrum Disorder (NMOSD)
NCT07557420NMOSD, Neuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals, Inc.
Phase 3
19
Beijing, Chengdu, Dongguan, Jinan, Shanghai, Shijiazhuang, Taiyuan, Wenzhou
2026-07-20
Recruiting
Phase Ib Study of Efsubaglutide Alfa Injection in Obese Adolescents
NCT07693426Adolescence Obesity
Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.
Phase 1
36
Beijing, Wuhan, Shenyang, Jinan
2026-07-16
Not yet open
SBRT Followed by Ipilimumab N01, Sintilimab, Nab-Paclitaxel and Gemcitabine for Locally Advanced Pancreatic Cancer
NCT07683221Pancreatic Cancer
Shandong Cancer Hospital and Institute
Phase 2
47
Jinan
2026-07-15
Recruiting
A Research Study to Investigate the Efficacy and Safety of HRS9531 Tablets in Participants With Type 2 Diabetes Mellitus
NCT07599410T2DM
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 2
240
Beijing, Jinan
2026-07-14
Recruiting
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
NCT07662135Type 2 Diabetes Mellitus, Type 2 Diabetes With Chronic Kidney Disease
AstraZeneca
Phase 3
900
Binzhou, Changsha, Chengdu, Hangzhou, Jinan, Liaocheng, Liuzhou, Luoyang
2026-07-06
Recruiting
A Study of SIM0689 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
NCT07660432Neoplasms, Malignant
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
472
Fuzhou, Zhengzhou, Changsha, Shenyang, Jinan, Hangzhou
2026-07-03
Recruiting
A Study on the Efficacy of Dual-Carrier-Frequency Transcranial Alternating Current Stimulation Modulating the Hippocampus for the Treatment of Chronic Non-Specific Low Back Pain
NCT07832188Chronic Pain
Qilu Hospital of Shandong University
Not applicable
60
Jinan
2026-07-03
Not yet open
Clinical Study of Traditional Chinese Medicine in the Treatment of Phlegm-dampness Intrinsic Precocious Puberty
NCT07637019Precocious Puberty
Children's Hospital of Fudan University
Not applicable
200
Xiamen, Guangzhou, Zhengzhou, Jinan, Shanghai
2026-07-01
Not yet open
Efficacy of Probiotics for OAB Patients With Anxiety
NCT07635212Overactive Bladder (OAB)
Qilu Hospital of Shandong University
Not applicable
218
Jinan
2026-07-01
Not yet open
Intraoperative Longitude-Latitude-Depth Localization Versus Preoperative CT-Guided Percutaneous Lung Puncture Localization for 0.8-2 cm Peripheral Pulmonary Nodules
NCT07675889Pulmonary Nodule, Solitary, Peripheral Pulmonary Nodules, Pulmonary Nodules
Qilu Hospital of Shandong University
Not applicable
274
Xingyi, Yinchuan, Jinan, Linqing
2026-07-01
Not yet open
Mazdutide for Adults With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled Trial (DREAM-PRE)
NCT07654062Prediabetes, Impaired Fasting Glucose, Impaired Glucose Tolerance (Prediabetes)
Shandong Provincial Hospital
Phase 4
150
Jinan
2026-07
Recruiting
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
NCT07489066Carcinoma, Non-Small-Cell Lung, Lung Cancer (NSCLC), Lung Neoplasms
Pfizer
Phase 2
120
Beijing, Guangzhou, Jinan
2026-06-30
Active, closed
A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight
NCT07662122Obesity, Overweight
Boehringer Ingelheim
Phase 2
342
Huzhou, Jinan, Luoyang, Nanjing, Ningbo, Qinhuangdao, Tianjin, Yichang
2026-06-30
Recruiting
Phase III Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above
NCT07817108Varicella-zoster Virus
Suzhou Abogen Biosciences Co., Ltd.
Phase 3
18,000
Jinan, Nanning, Shijiazhuang, Zhejiang
2026-06-27
Recruiting
An Extension Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer in China
NCT07604766Platinum-resistant Ovarian Cancer
Genmab
Phase 3
82
Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Hangzhou, Harbin, Jinan
2026-06-26
Recruiting
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
NCT07555938Multiple Myeloma
Hoffmann-La Roche
Phase 3
380
Guangzhou, Nanjing, Qingdao, Kunming, Hangzhou, Jinan, Nanning, Shanghai
2026-06-23
Recruiting
GenSci144 Tablets Phase I Clinical Trial
NCT07685210Phenylketonuria
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
48
Jinan
2026-06-22
Not yet open
Thyroxine Supplementation in Small for Gestational Age (SGA) Infants With Birth Weight <1500g and TSH 6-20 mIU/ml
NCT07625722Thyroid Function, Preterm, SGA and Growth, Neurodevelopment Outcome
Shandong Provincial Hospital
Not applicable
106
Jinan
2026-06-20
Not yet open
Transcutaneous Tibial Nerve Stimulation (TTNS) Patch in the Treatment of Patients With Lower Urinary Tract Symptoms (LUTS) After Benign Prostatic Hyperplasia (BPH) Surgery
NCT07710794Lower Urinary Tract Symptoms (LUTS), BPH (Benign Prostatic Hyperplasia)
Qilu Hospital of Shandong University
Not applicable
70
Jinan
2026-06-20
Not yet open
One-Click Autofocus Versus Segmented Focus in Gastric Endoscopy
NCT07664813Stomach Neoplasms, Stomach Diseases
Shandong University
Not applicable
93
Jinan
2026-06-18
Recruiting
Clinical Evaluation of 177Lu-FAP-VG11 Injection in Patients With Fibroblast Activation Protein -Positive Advanced Solid Tumours
NCT07808177Fibroblast Activation Protein (FAP)-Positive Advanced Solid Tumours
Shandong Cancer Hospital and Institute
Phase EARLY_PHASE1
7
Jinan
2026-06-17
Not yet open
Evaluation of the Safety, Tolerability, Immunogenicity and Preliminary Efficacy of BBM-C101 Injection in Patients With Cervical High-Grade Squamous Intraepithelial Lesion(HSIL)
NCT07668960High-grade Squamous Intraepithelial Lesions of the Cervix Associated With Human Papillomavirus (HPV) Type 16 and/or HPV Type 18 Infection
Shanghai Mianyi Biopharmaceutical Co., Ltd.
Phase 1/2
60
Beijing, Chongqing, Zhangzhou, Jinan
2026-06-17
Recruiting
Immune Mechanisms and ECMO Strategies for Moderate-to-Severe ARDS
NCT07726940Acute Respiratory Distress Syndrome (ARDS)
Southeast University, China
Observational
1,776
Beijing, Fuzhou, Nanjing, Jinan, Chengdu, Hangzhou, Changchun, Chenzhou
2026-06-16
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
NCT07357727Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (PPV-MF), Post-essential Thrombocythemia Myelofibrosis (PET-MF)
Novartis Pharmaceuticals
Phase 3
460
Hefei, Guangzhou, Wuhan, Nanjing, Nantong, Changchun, Jinan, Yantai
2026-06-16
Recruiting
A Study on Gastrointestinal Cancer Screening Using a Multi-Targeted Combined Detection Model
NCT07712107Gastrointestinal Tumors
Xijing Hospital
Not applicable
10,000
Zhaoqing, Jinan, Mianyang, Wuwei, Wuxi
2026-06-15
Not yet open
A Randomized, Multicenter, Open-label, Active-controlled Phase Ib Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Multiple Intravaginal Doses of GenSci142 in Patients With Bacterial Vaginosis (BV)
NCT07663838Randomized, Open-label, Safety, Tolerability
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
30
Beijing, Nanjing, Nanchang, Changchun, Jinan, Taiyuan, Tianjin
2026-06-15
Active, closed
Study of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW107) as Prophylactic Treatment.
NCT07684898Severe Hemophilia A
Hangzhou Gensciences Biopharmaceutical Co., Ltd.
Phase 3
60
Tianjin, Fuyang, Fuzhou, Guangzhou, Hefei, Jinan, Kunming, Nanning
2026-06-12
Recruiting
A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors
NCT07623369Solid Tumor, Non-small Cell Lung Cancer, Hepatocellular Carcinoma, Colorectal Cancer
Huahui Health
Phase 1
299
Jinan
2026-06-11
Not yet open
A Novel Wearable Transcutaneous Tibial Nerve Stimulation (TTNS) Device in the Treatment of Patients With Overactive Bladder (OAB) and Nocturia
NCT07635251Overactive Bladder (OAB), Nocturia
Qilu Hospital of Shandong University
Not applicable
80
Jinan
2026-06-10
Recruiting
A Study to Assess the Effect of HRS-1301 on the Pharmacokinetics of Midazolam and Atorvastatin in Healthy Participants
NCT07608705Hyperlipidemias
Shandong Suncadia Medicine Co., Ltd.
Phase 1
16
Jinan
2026-06-08
Not yet open
Zanubrutinib Induction Followed by Delayed Fixed-Duration Combination With Sonrotoclax for CLL/SLL๏ผšStop Trial 2.0
NCT07682415CLL / SLL
Yi Shuhua
Phase 2
60
Shenzhen, Zhengzhou, Changsha, Nanjing, Nanchang, Jinan, Tianjin
2026-06-08
Not yet open
Concordance Between Large Language Model and Multidisciplinary Team Recommendations in Rectal Cancer
NCT07595107Rectal Cancer
Shandong Cancer Hospital and Institute
Observational
180
Jinan
2026-06-01
Recruiting
Nano-Megestrol Acetate for Cancer Cachexia in Advanced Pancreatic Cancer
NCT07408505Advanced Pancreatic Ductal Adenocarcinoma, Cancer Anorexia-Cachexia Syndrome
Shandong Cancer Hospital and Institute
Not applicable
56
Jinan
2026-06-01
Not yet open
Molecular Subtype-Guided Postoperative Radiotherapy for Phyllodes Tumor of the Breast: A Randomized Controlled Trial
NCT07657169Radiotherapy, Adjuvant, Phyllodes Breast Tumor, Prognosis, Molecular Typing
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
160
Guangzhou, Shenzhen, Jinan, Qingdao
2026-06-01
Not yet open
A Phase I Study of HW241045 in Healthy Subjects
NCT07593690Idiopathic Pulmonary Fibrosis (IPF)
Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.
Phase 1
102
Jinan
2026-06
Recruiting
Osimertinib Combined With Chemotherapy in Patients Who Had Distant Recurrence After Adjuvant Osimertinib for EGFRm Resectable SIB-IIIA NSCLC.
NCT07279935Non-small Cell Lung Cancer
AstraZeneca
Phase 4
100
Beijing, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Hefei, Jinan
2026-05-26
Recruiting
Brain Network Characteristics of Pain Patients Based on Magnetoencephalography
NCT07809542Muscle Pain
Qilu Hospital of Shandong University
Observational
1,200
Jinan
2026-05-26
Recruiting
Observation of Iris Blood Flow Via OCTA in Diabetic Neovascular Glaucoma
NCT07722910Neovascular Glaucoma, Type 2 Diabetes
Qilu Hospital of Shandong University
Observational
98
Jinan
2026-05-23
Recruiting
A Phase I Clinical Study of HLX316 in Participants With Advanced/Metastatic Solid Tumors
NCT07541534Advanced/Metastatic Solid Tumors
Shanghai Henlius Biotech
Phase 1
41
Chongqing, Jinan, Shanghai, Wuhan
2026-05-22
Recruiting
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
NCT07525206Colorectal Cancer
AbbVie
Phase 3
990
Beijing, Guangzhou, Nanning, Wuhan, Changchun, Shenyang, Yinchuan, Jinan
2026-05-22
Not yet open
A Single-Center Clinical Study to Evaluate the Efficacy and Safety of a Suture-Free Ophthalmic Hydrogel for Ocular Surface Tissue Adhesion
NCT07608367Cornea Disease
Suxia Li
Not applicable
20
Jinan
2026-05-22
Recruiting
Bioequivalence Study of Ferric Carboxymaltose Injection in Healthy Chinese Participants Under Fasting Conditions
NCT07606105Healthy Adult
Sichuan Huiyu Pharmaceutical Co., Ltd
Phase 1
70
Jinan
2026-05-19
Recruiting
A Study of TAK-755 in Adults With Acute Ischemic Stroke
NCT07392450Acute Ischemic Stroke
Takeda
Phase 2
222
Beijing, Nanyang, Xuzhou, Jinan, Liaocheng, Linyi, Datong, Linfen
2026-05-17
Recruiting
Adaptive DBS for PD
NCT07635823Parkinson Disease(PD)
Beijing Pins Medical Co., Ltd
Not applicable
60
Hefei, Beijing, Guangzhou, Changsha, Nanjing, Jinan, Chengdu
2026-05-16
Recruiting
Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients
NCT06704074Stroke
Qilu Hospital of Shandong University
Not applicable
86
Jinan
2026-05-09
Recruiting
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
NCT07415031Solid Tumors
Mirati Therapeutics Inc.
Phase 2
170
Beijing, Xiamen, Zhengzhou, Changsha, Nanjing, Nanchang, Shenyang, Jinan
2026-05-06
Recruiting
Single vs. Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Intervention With DCB-only Strategy (KONG-FREEDOM-I)
NCT07587099Coronary Heart Disease (CHD)
Gan Lijun
Not applicable
2,170
Beijing, Haikou, Harbin, Nanchang, Heze, Jinan, Jining, Liaocheng
2026-05-04
Recruiting
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
NCT07611110Metastatic Castration-resistant Prostate Cancer
AstraZeneca
Phase 3
670
Beijing, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Jinan, Nanjing
2026-05-04
Recruiting
Comparison of Double-tract and Tubular Gastric Anastomosis in Proximal Gastric Cancer
NCT07635836Gastric Cancer (GC), Double-tract Reconstruction, Tubular Gastric Anastomosis
Qilu Hospital of Shandong University
Not applicable
52
Jinan
2026-05-01
Not yet open
A Mass Balance Study of [14C]HRS-1780 in Healthy Adult Male Subjects
NCT07557407Chronic Kidney Diseases
Shandong Suncadia Medicine Co., Ltd.
Phase 1
6
Jinan
2026-05
Not yet open
A Phase I Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of HS-10506 in Healthy Chinese Adult Participants
NCT07535970Healthy Participants
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1
20
Jinan
2026-04-30
Not yet open
Covered vs Bare Metal Stents for Atherosclerotic Renal Artery Stenosis
NCT07566065Atherosclerotic Renal Artery Stenosis, Hypertension, Renal Artery Stenosis
Chinese Academy of Medical Sciences, Fuwai Hospital
Not applicable
150
Guangzhou, Harbin, Zhengzhou, Nanjing, Nanchang, Dalian, Jinan, Qingdao
2026-04-30
Recruiting
A Phase II Clinical Trial of SHR-1826 for Non-Small Cell Lung Cancer
NCT07489716Non-Small Cell Lung Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 2
90
Jinan
2026-04-29
Recruiting
Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis
NCT07303777Atherosclerosis Cardiovascular Disease, ASCVD, ASCVD Management
Atom Therapeutics Co., Ltd
Phase 2
200
Beijing, Dalian, Guangzhou, Hangzhou, Jinan, Nanjing, Shanghai, Suzhou
2026-04-23
Recruiting
An Artificial Intelligence System for Multimodal, Multi-class Diagnosis of Pancreatic Cystic Lesions Based on Endoscopic Ultrasonography
NCT07543263Pancreatic Cystic Lesion (PCL)
Qilu Hospital of Shandong University
Observational
176
Jinan
2026-04-20
Not yet open
A Exploratory Study on Untreated Follicular Lymphoma With Orelabrutinib, Tafasitamab, and Lenalidomide
NCT07585747Follicular Lymphoma
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
27
Shenzhen, Zhengzhou, Nanchang, Jinan, Tianjin
2026-04-15
Active, closed
Study of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW107) On-Demand Treatment
NCT07663903Severe Hemophilia A
Hangzhou Gensciences Biopharmaceutical Co., Ltd.
Phase 3
60
Tianjin, Fuyang, Fuzhou, Ganzhou, Guangzhou, Hefei, Huai'an, Jinan
2026-04-14
Recruiting
A Study of Zovaglutide (ZT002 Injection) in Participants With Impaired Kidney Function and Healthy Participants
NCT07443059Overweight , Obesity
Beijing QL Biopharmaceutical Co.,Ltd
Phase 1
40
Xiamen, Jinan, Chengdu
2026-04-13
Rows per page Showing 1–100 of 785
1 2 3 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/jinan

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 785 of those studies with a site in Jinan.

How many clinical trials are recruiting in Jinan?

488 of the 785 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 130 have not yet opened recruitment, 149 are active but closed to new participants, and 18 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Jinan), 785 studies
PhaseStudiesRecruitingShare
Phase 215910020.3%
Not applicable1397017.7%
Observational1389717.6%
Phase 31366917.3%
Phase 1957212.1%
Phase 1/266468.4%
Phase 430193.8%
Phase 2/316112%
Phase EARLY_PHASE1640.8%

Most active sponsors

Lead sponsors with the most studies (Jinan)
Lead sponsorStudiesRecruiting
Qilu Hospital of Shandong University11472
Qianfoshan Hospital3219
Shandong Cancer Hospital and Institute3125
AstraZeneca269
Shandong University2615
Eli Lilly and Company217
Shandong Provincial Hospital1510
Hoffmann-La Roche137
The Second Hospital of Shandong University139
Jiangsu Simcere Pharmaceutical Co., Ltd.108
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.